Public Call for Evidence for the International Commission on the Clinical Use of Human Germline Genome Editing

Tuesday, September 10, 2019

Click here to begin the process.

The Royal Society and the U.S. National Academies of Sciences and Medicine have convened an international commission to develop a framework for considering technical, scientific, medical, regulatory, and ethical requirements for human germline genome editing, should society conclude such applications are acceptable.
 
To inform its deliberations, the Commission is engaging with external expertise and invites responses to the questions below.  This call for evidence is open until Friday 27 September 2019.  You may limit responses to those questions most relevant to your particular area of expertise. When appropriate, you are encouraged to provide citations and/or links to evidence in support of your responses. 
 
The U.S. National Academies will list all written submissions in a Public Access File (PAF) established for the International Commission. These submissions will be made available to the public upon request. If you prefer that personally identifiable details not be included in the PAF, you must not include your name, contact information, or other such specifics in your comments.  

Because respondents to the call for evidence are self-selected, the National Academies and Royal Society will not necessarily use submissions to judge the prevalence of attitudes or opinions.